杭州睿田品牌管理有限公司
20-99人
公司优势
20,861+ 岗位更新等你来订阅
一键订阅最新的岗位，每周送达
🎉恭喜你，订阅成功
继续订阅您可以在邮箱中随时取消订阅
深圳肯特仕贸易有限公司为外商独资贸易公司，总部KENTEX CORP.位于美国COLUMBUS, OHIO，于深圳罗湖区设有独立办事处。
KENTEX主营家具用品、厨房用品、餐饮用品及建筑板材等四大板块，与美国大型连锁超市保持紧密合作关系，既是可靠的供应商，也是高效的采购代理。其合作超市超8000家，国内稳定供应商约1000家。
KENTEX在美国拥有自有仓库，可容纳40个货柜，配合稳定的合作物流体系，确保货物高效流通。其物流团队精心挑选最佳船期与航线，保障时效性。
销售团队由美国本土专业人士组成，精通语言与沟通，精准把握客户需求与市场动态；采购团队协同中美双方运作，深圳办公室负责供应链管理和专业伙伴对接，推动持续发展。
公司采用西式化管理，强调人性化，尊重人权，营造轻松愉快的工作氛围，同事间和睦相处，无内耗，工作与生活平衡良好。
公司提供优厚福利：实行5天7.5小时工作制，周六轮班，确保月度至少3个双休日；三个月试用期；每月餐补300元；每周一次下午茶与畅聊会；享有法定节假日及年终奖。
厨十二餐饮管理(东莞)有限公司，成立于2023年3月31日，位于广东省东莞市南城街道鸿福路100号104室，所属行业为正餐服务，员工规模为1-49人。
山东新晨置业有限公司，公司规模少于50人，公司类型为民营企业，所属行业为房地产。
珠海好印宝打印耗材有限公司是一家拥有26年复印机兼容耗材、配件研发、生产、销售经验的综合型企业。目前，“好印宝”、“HYB TONER”、“Zeus toner”、“立肯”等自主品牌已销往105个国家，成为1000多家复印影像耗材进口商的首选，是全球复印机耗材的国际知名品牌。公司研发实力雄厚，培训系统完善，产品竞争力强，是各方人才施展才华的平台。公司每年投入大量资金用于品牌宣传、品牌建设、代理商支持、国际展会、国外市场调研、B2B平台及SNS多平台推广，拥有充足的客户资源供销售人员进行业务开发。公司重视专利，已自主研发并注册专利670多项。集团公司产销一体化，处于复印机影像耗材研发的前沿，并获得多项国际质量认证。
CStone Pharmaceuticals is an innovative, research-driven biopharmaceutical enterprise dedicated to pioneering the development of cutting-edge therapeutic medications. Situated in both Shanghai and Suzhou, the company boasts a leadership team comprised of experienced executives from leading multinational pharmaceutical corporations. In July 2016, CStone disclosed the successful conclusion of its Series A funding round, securing a total investment of $150 million (approximately 975 million RMB). This round was co-invested by three prominent industry investors: Oriza Seed Venture Capital (Oriza Seed), Boyu Capital, and WuXi Healthcare Ventures (WXHV).
With an unwavering commitment to addressing the critical healthcare needs of Chinese patients, CStone's extensive pipeline encompasses five therapeutic areas: oncology, cardiovascular diseases, rheumatoid arthritis, hematology, and autoimmune disorders. The company's strategic focus on immuno-oncology serves as its cornerstone, aiming to propel Chinese research onto the global stage through its world-class research and development capabilities, an innovative drug portfolio, and an open innovation approach.
CStone Pharmaceuticals is a pioneering, research-focused biopharmaceutical company headquartered in Shanghai and Suzhou, China. Its executive team comprises seasoned professionals from top-tier multinational pharmaceutical firms. In July 2016, the company successfully concluded its Series A funding round, attracting a total investment of $150 million (equivalent to approximately 975 million RMB). This round was jointly supported by three distinguished industry investors: Oriza Seed Venture Capital (Oriza Seed), Boyu Capital, and WuXi Healthcare Ventures (WXHV).
Driven by a mission to meet the pressing medical needs of Chinese patients, CStone's comprehensive product pipeline spans across five therapeutic sectors: oncology, cardiovascular diseases, rheumatoid arthritis, hematology, and autoimmune diseases. With immuno-oncology at the heart of its strategic focus, the company aspires to position Chinese research on the global stage, leveraging its world-class research and development expertise, innovative drug portfolio, and an open innovation philosophy.